Vigilant Capital Management’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $232K | Buy |
2,304
+85
| +4% | +$8.5K | 0.02% | 137 |
|
|
2023
Q1 | $204K | Sell |
2,219
-137
| -6% | -$12K | 0.02% | 141 |
|
|
2022
Q4 | $214K | Buy |
2,356
+79
| +3% | +$6.65K | 0.02% | 142 |
|
|
2022
Q3 | $173K | Hold |
2,277
| – | – | 0.02% | 155 |
|
|
2022
Q2 | $192K | Hold |
2,277
| – | – | 0.02% | 157 |
|
|
2022
Q1 | $200K | Hold |
2,277
| – | – | 0.02% | 171 |
|
|
2021
Q4 | $199K | Buy |
2,277
+965
| +74% | +$80.1K | 0.01% | 197 |
|
|
2021
Q3 | $107K | Hold |
1,312
| – | – | 0.01% | 200 |
|
|
2021
Q2 | $120K | Buy |
1,312
+35
| +3% | +$3.12K | 0.01% | 191 |
|
|
2021
Q1 | $109K | Buy |
1,277
+58
| +5% | +$5.21K | 0.01% | 184 |
|
|
2020
Q4 | $115K | Hold |
1,219
| – | – | 0.01% | 169 |
|
|
2020
Q3 | $106K | Buy |
1,219
+1,103
| +951% | +$95.6K | 0.01% | 174 |
|
|
2020
Q2 | $10K | Buy |
116
+39
| +51% | +$3.37K | ﹤0.01% | 282 |
|
|
2020
Q1 | $6K | Sell |
77
-1,157
| -94% | -$103K | ﹤0.01% | 306 |
|
|
2019
Q4 | $117K | Buy |
1,234
+750
| +155% | +$67.3K | 0.01% | 185 |
|
|
2019
Q3 | $42K | Buy |
484
+77
| +19% | +$6.91K | 0.01% | 269 |
|
|
2019
Q2 | $37K | Buy |
+407
| New | +$34.4K | ﹤0.01% | 278 |
|
|
2018
Q3 | – | Sell |
-355
| Closed | -$24K | – | 478 |
|
|
2018
Q2 | $24K | Buy |
355
+128
| +56% | +$8.83K | ﹤0.01% | 335 |
|
|
2018
Q1 | $16K | Buy |
227
+17
| +8% | +$1.29K | ﹤0.01% | 324 |
|
|
2017
Q4 | $16K | Buy |
210
+143
| +213% | +$10.8K | ﹤0.01% | 310 |
|
|
2017
Q3 | $5K | Hold |
67
| – | – | ﹤0.01% | 279 |
|
|
2017
Q2 | $5K | Buy |
+67
| New | +$4.75K | ﹤0.01% | 250 |
|
|
2016
Q3 | – | Sell |
-112
| Closed | -$8K | – | 342 |
|
|
2016
Q2 | $8K | Sell |
112
-625
| -85% | -$43.2K | ﹤0.01% | 290 |
|
|
2016
Q1 | $48K | Sell |
737
-79,261
| -99% | -$5.39M | 0.01% | 150 |
|
|
2015
Q4 | $6.17M | Buy |
79,998
+2,366
| +3% | +$188K | 1.25% | 39 |
|
|
2015
Q3 | $6.39M | Sell |
77,632
-942
| -1% | -$83.8K | 1.28% | 42 |
|
|
2015
Q2 | $6.92M | Sell |
78,574
-1,657
| -2% | -$152K | 1.25% | 38 |
|
|
2015
Q1 | $7.09M | Sell |
80,231
-2,361
| -3% | -$209K | 1.34% | 35 |
|
|
2014
Q4 | $6.86M | Buy |
82,592
+20,059
| +32% | +$1.66M | 1.36% | 35 |
|
|
2014
Q3 | $5.27M | Sell |
62,533
-854
| -1% | -$69.1K | 1.14% | 45 |
|
|
2014
Q2 | $5.14M | Sell |
63,387
-3,455
| -5% | -$272K | 1.14% | 44 |
|
|
2014
Q1 | $5.09M | Sell |
66,842
-1,713
| -2% | -$125K | 1.2% | 43 |
|
|
2013
Q4 | $4.94M | Sell |
68,555
-580
| -0.8% | -$40.3K | 1.21% | 43 |
|
|
2013
Q3 | $4.75M | Sell |
69,135
-1,674
| -2% | -$111K | 1.34% | 42 |
|
|
2013
Q2 | $4.49M | Buy |
+70,809
| New | +$4.61M | 1.34% | 39 |
|
Other funds holding NVS
Vigilant Capital Management's NVS Position: Q2 2023 in Review
Vigilant Capital Management increased its Novartis (NVS) stake by 3.8% in Q2 2023, buying an estimated $8.5K and bringing the position to 2,304 shares worth $232K. The position accounts for 0.02% of the portfolio, ranked #137.
Vigilant Capital Management first reported a position in NVS in Q2 2013 and has held it in 35 quarters since. The position peaked at $7.09M in Q1 2015. 1,202 funds tracked by Wall St. Rank hold NVS as of Q2 2023.
- Vigilant Capital Management held 2,304 shares of Novartis worth $232K as of Q2 2023.
- Vigilant Capital Management bought 85 Novartis shares in Q2 2023, an estimated $8.5K.
- Novartis made up 0.02% of Vigilant Capital Management's portfolio in Q2 2023, its #137 holding.
- Vigilant Capital Management first reported a position in Novartis in Q2 2013 and has held it in 35 quarters since.
- Vigilant Capital Management's Novartis position peaked at $7.09M in Q1 2015.
- 1,202 funds tracked by Wall St. Rank held Novartis as of Q2 2023.
Based on Vigilant Capital Management's 13F filing for Q2 2023, filed 8 Aug 2023.